Unicycive Therapeutics, Inc. UNCY Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.52Beat by $0.18
EPS estimate-$0.70
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$22.2M
EPS estimate-$0.47
Versus estimates
Diluted EPS
Ask the moment Unicycive Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Unicycive Therapeutics, Inc. report Q2 2025 earnings?
- Unicycive Therapeutics, Inc. (UNCY) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Unicycive Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Unicycive Therapeutics, Inc. reported eps of $-0.52 for Q2 2025.
- Did Unicycive Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.70 by $0.18.
- How did Unicycive Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 246.7% from $-0.15.
- Where can I find Unicycive Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-076007) directly on SEC EDGAR. The filing index links above go to sec.gov.